Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Revolution Medicines (RVMD) over the last 6 years, with Q3 2025 value amounting to 0.0.

  • Revolution Medicines' Asset Utilization Ratio fell 127496.6% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year decrease of 127496.6%. This contributed to the annual value of 0.01 for FY2023, which is 8234.66% down from last year.
  • Revolution Medicines' Asset Utilization Ratio amounted to 0.0 in Q3 2025, which was down 127496.6% from 0.0 recorded in Q3 2024.
  • In the past 5 years, Revolution Medicines' Asset Utilization Ratio ranged from a high of 0.06 in Q1 2021 and a low of 0.0 during Q3 2025
  • In the last 5 years, Revolution Medicines' Asset Utilization Ratio had a median value of 0.04 in 2022 and averaged 0.03.
  • Per our database at Business Quant, Revolution Medicines' Asset Utilization Ratio soared by 826.27% in 2022 and then plummeted by 127496.6% in 2025.
  • Quarter analysis of 5 years shows Revolution Medicines' Asset Utilization Ratio stood at 0.04 in 2021, then grew by 8.26% to 0.04 in 2022, then crashed by 82.4% to 0.01 in 2023, then crashed by 94.54% to 0.0 in 2024, then plummeted by 1274.97% to 0.0 in 2025.
  • Its Asset Utilization Ratio stands at 0.0 for Q3 2025, versus 0.0 for Q3 2024 and 0.0 for Q2 2024.